Leigh Hsu
Corporate Officer/Principal chez CARSGEN THERAPEUTICS HOLDINGS LIMITED
Postes actifs de Leigh Hsu
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CARSGEN THERAPEUTICS HOLDINGS LIMITED | Corporate Officer/Principal | 01/06/2017 | - |
Historique de carrière de Leigh Hsu
Anciens postes connus de Leigh Hsu
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ACADIA PHARMACEUTICALS INC. | Corporate Officer/Principal | - | - |
Lpath, Inc.
 Lpath, Inc. BiotechnologyHealth Technology Lpath, Inc. operates as a biotechnology company, which focuses on the discovery and development of lipidomic-based therapeutic antibodies, an emerging field of medical science that targets bioactive signaling lipids to treat a wide range of human diseases. It develops three drug candidates, each of them into clinical trials, and built evidence to support their approach of targeting bioactive lipids to treat a wide range of diseases. The company was founded by Roger Allen Sabbadini in September 1997 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 19/02/2013 | - |
Formation de Leigh Hsu
| University of California San Diego | Doctorate Degree |
| University of California, Irvine | Masters Business Admin |
Statistiques
Internationale
| Etats-Unis | 5 |
| Chine | 2 |
Opérationnelle
| Corporate Officer/Principal | 3 |
| Doctorate Degree | 1 |
| Masters Business Admin | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| CARSGEN THERAPEUTICS HOLDINGS LIMITED | Health Technology |
| ACADIA PHARMACEUTICALS INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Lpath, Inc.
Lpath, Inc. BiotechnologyHealth Technology Lpath, Inc. operates as a biotechnology company, which focuses on the discovery and development of lipidomic-based therapeutic antibodies, an emerging field of medical science that targets bioactive signaling lipids to treat a wide range of human diseases. It develops three drug candidates, each of them into clinical trials, and built evidence to support their approach of targeting bioactive lipids to treat a wide range of diseases. The company was founded by Roger Allen Sabbadini in September 1997 and is headquartered in San Diego, CA. | Health Technology |
